MedTrace Logo

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

NCT02875704 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2022-09-26

No results posted yet for this study

Summary

In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.

Conditions

Interventions

OTHER

Anterior Chamber (AC) Tap

Aqueous Samples will be collected for measurement of biomarkers

Sponsors & Collaborators

Principal Investigators

  • Peter A Campochiaro, MD · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-03
Primary Completion
2022-06-06
Completion
2022-09-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02875704 on ClinicalTrials.gov